Drug Trial Radar · NCT06053567
Community-based Smoking Cessation Treatment for Adults With High Stress Sensitivity.
Last checked: Nov 20, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
360
Planned (sponsor's estimate)
Start
Dec 27, 2023
Primary completion
Mar 31, 2029
Study completion Jun 30, 2029
Sponsor
- Lead sponsor
- Jasper A. SmitsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- University of Houston; University of Oklahoma; National Cancer Institute (NCI); YMCA
- First posted
- Sep 25, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Anxiety sensitivity, reflecting the fear of bodily sensations, is a risk factor for the maintenance and relapse of smoking. This study is designed to address the question - is a smoking cessation intervention personalized to high anxiety sensitive smokers and adapted for implementation by the YMCA effective among racially/ethnically diverse samples?
Conditions
- Nicotine Dependence
Interventions
Aerobic ExerciseBehavioral
Participants will select a YMCA branch and will be assigned a personal fitness instructor who will oversee a 15-week exercise intervention. The weekly exercise prescription is 75 minutes of aerobic training.
CounselingBehavioral
Participants will receive the standard tobacco cessation package of up to 5 proactive interactions from the Texas Tobacco Quitline (TTQ). Interactions are typically phone calls, but can be chat or live text if the participant prefers. Interaction 1 is for assessment and quit date planning, Interaction 2 occurs prior to the quit date and can be a group session, Interaction 3 occurs shortly following the quit date, and Interactions 4 and 5 are for relapse prevention if the smoker has quit or problem solving if they have not quit. TTQ also offers a tobacco cessation text messaging program and access to a web portal with a variety of cessation resources.
Nicotine patchDrug
On the target quit day (week 6), participants will be provided 8 weeks of nicotine replacement therapy (24-hour transdermal nicotine patches \[TNP\]).
Primary outcomes
What the sponsor says the trial is designed to measure.
- 7-day point prevalence abstinence (PPA) at 6-month follow-upTime frame: Protocol week 30, which is 24 weeks (6 months) after the quit attempt (set at week 6)
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of Texas at Austin
Austin, Texas · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.